
    
      Total 40 subjects will be randomized for participation into the study The subjects are
      Hemo-dialysis Dependent Chronic Kidney Disease (CKD) Stage 5D patients who are able to give
      informed consent to the study, and taking the phosphate binder sevelamer carbonate tablets.
    
  